All News UCB SA OTC Markets

Equities

UCBJY

US9034801012

Market Closed - OTC Markets Other stock markets 01:15:21 25/05/2024 am IST			5-day change	1st Jan Change
69.56 ^USD	-0.13%		+1.19%	+59.54%

11/04	Berenberg Reiterates UCB's Purchase Rating, Raises PT	MT
11/04	UCB : Berenberg, Buy, raises its price target	CF

All News

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

UCB : announces publication in The Lancet of phase 3 bimekizumab▼ trials in moderate to severe hidradenitis suppurativa	23/05	PU
UCB - Acquisition of own shares	20/05	AQ
UCB : Transparency notification Wellington	17/05	PU
UCB : Acquisition of own shares	17/05	PU
UCB - Acquisition of own shares	13/05	AQ
UCB : Acquisition of own shares	10/05	PU
UCB presents final open-label extension F data at International Child Neurology Congress Annual Meeting	09/05	AQ
UCB : presents final open-label extension F®▼(fenfluramine) data at International Child Neurology Congress (ICNC) Annual Meeting	08/05	PU
UCB : presents final open-label extension FINTEPLA®▼(fenfluramine) data at International Child Neurology Congress (ICNC) Annual Meeting	08/05	PU
UCB - Acquisition of own shares	06/05	AQ
UCB : Acquisition of own shares	26/04	PU
Pioneering innovation, fueling growth: UCB's commitment to delivering differentiated solutions	26/04	PU
Ex-dividend day for final dividend	26/04	FA
UCB : General Meeting of Shareholders 2024	25/04	PU
UCB : receives European Commission approval for BIMZELX▼(bimekizumab) as the first IL-17A and IL-17F biologic for moderate to severe hidradenitis suppurativa	22/04	PU
UCB : FINTEPLA▼ (fenfluramine) oral solution approved in Japan for adjunctive treatment of seizures associated with Lennox-Gastaut syndrome (LGS)	17/04	PU
UCB presents new data highlighting developments across expansive neurology portfolio at 76th American Academy of Neurology Annual Meeting	15/04	AQ
UCB : Latest real-world evidence presented at WCO-IOF-ESCEO assesses how EVENITY▼ (romosozumab) can help to close the treatment gap in osteoporosi	12/04	PU
UCB : presents new data highlighting developments across expansive neurology portfolio at 76th American Academy of Neurology (AAN) Annual Meeting	12/04	PU
Berenberg Reiterates UCB's Purchase Rating, Raises PT	11/04	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

UCB : UCB all set to reach new highs

March 08, 2024 at 09:40 pm IST